Staging ::: VER CORREOS
España
Acceder

Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients with Prima

2 respuestas
Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients with Prima
Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients with Prima

CÓDIGO AMIGO

Gestión inteligente del capital con Trade Republic: IBAN español y 2% de remuneración sin límite de saldo

¡Quiero la oferta!
#2

Re: Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients wit...
steri
Mucha demanda en la preapertura
#3

Re: Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients wit...
steri
+80%